Cardiovascular Events in Adults with Type 2 Diabetes and ASCVD Initiating Once-Weekly Semaglutide vs DPP-4is in the USA
Inzucchi S, Tan X, Liang Y, Yedigarova L, Xie L, de Havenon A. Cardiovascular Events in Adults with Type 2 Diabetes and ASCVD Initiating Once-Weekly Semaglutide vs DPP-4is in the USA. Diabetes Therapy 2024, 1-17. PMID: 39688779, DOI: 10.1007/s13300-024-01678-4.Peer-Reviewed Original ResearchHealth care resource utilizationAtherosclerotic cardiovascular diseaseDPP-4i usersDPP-4isGLP-1 RAsOnce-weekly semaglutideMedical costsType 2 diabetesDPP-4iDecreased risk of strokeRisk of cardiovascular outcomesCardiovascular eventsOnce-weekly GLP-1 RAsPeptide 1 receptor agonistsTotal medical costsDipeptidyl peptidase 4 inhibitorsOccurrence of cardiovascular eventsHigh-risk patientsRisk of strokeObservational cohort analysisData Mart DatabaseOutpatient visitsDecreased riskSemaglutide treatmentBaseline characteristicsHow Much More Time Neurologic Examination Adds to Outpatient Visits
Ney J, Wilson A, Raphaelson M, de Havenon A. How Much More Time Neurologic Examination Adds to Outpatient Visits. Neurology Clinical Practice 2024, 15: e200404. PMID: 39649023, PMCID: PMC11620545, DOI: 10.1212/cpj.0000000000200404.Peer-Reviewed Original ResearchSurvey design variablesPatient visitsNational Ambulatory Medical Care SurveyStrong doctor-patient relationshipCost of careDoctor-patient relationshipSubgroup analysisNeurological examinationMedical decision makingNeurologist visitCare SurveyAmbulatory careInsurance statusOutpatient visitsPatient accessAnnual visitsLonger visitsVisit informationGeographic regionsVisit timeNeurological diagnosisVisits